Abstract
During the past two decades, revolutionary changes in our understanding of both the pathogenesis and the treatment of acute myocardial infarction have resulted in impressive gains in survival among patients hospitalized for this condition. The notable exception to the overall 25 to 35 percent relative reduction in early mortality that has occurred as a result of myocardial reperfusion1 is among patients in whom myocardial infarction is complicated by cardiogenic shock. Such patients make up 7 to 10 percent of the patients hospitalized for acute myocardial infarction. Characterized by hypotension and organ hypoperfusion, cardiogenic shock has an estimated mortality rate of . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
